hiv prevention study halted due to lack of benefit
a trial designed to test whether a drug made by gilead sciences inc could prevent hiv infection in women at high risk of exposure to the virus was halted early after investigators determined it would probably not be effective.
http://feeds.reuters.com/~r/reuters/healthnews/~3/oapcwhi3ir8/us-gilead-idustre73h62620110419
8364
19 Apr 2011 04:28:54
reuters
health